Hypothyroidism Clinical Trial
Official title:
"5010 Clinical Research Programme"of Sun Yat-sen University
Iodine 131 (131I） treatment on Graves disease and Graves ophthalmopathy relationship has always been the focus of debate. Majority view is that the current treatment does not increase 131I Graves ophthalmopathy, therefore,Graves disease associated with exophthalmos is not a contraindication of 131I treatment. While treatment with corticosteroids, a timely corrective measures to be effective in preventing Graves ophthalmopathy adverse effects. But the merger with severe proptosis in patients with Graves , especially infiltrative exophthalmos , the application of 131I treatment will induce or aggravate not yet reached consensus, so, the 131I treatment is still very careful , mainly due to plaque prospective study and visual assessment is not lack of uniform standards, and a variety of factors (including smoking, work status, and 131I treatment of thyroid doses, etc.) may also interfere or influence the ultimate effect of 131I on the Graves ophthalmopathy. In the view of this situation Graves disease patients with Graves ophthalmopathy could be 131I treatment or not, how to dose adjustments, and the use of which required treatment with systemic issues such as research, explore treatment exophthalmos reduction and mitigation of increased proptosis reasonable treatment of symptoms. To further promote the standardization of 131I treatment of Graves disease on basis.
no more description ;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Investigator), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05975866 -
The Effects of an Anti-inflammatory Diet With or Without Curcumin Supplementation on Anthropometric Measurements, Concentrations of Thyroid Hormones, Anti-TPO, and Systemic Inflammation in Plasma and NFK-B in Peripheral Blood Mononuclear Cells in Patients With Hashimato
|
N/A | |
| Not yet recruiting |
NCT05334771 -
Early Detection of Endolymphatic Hydrops in Hypothyroid Patients
|
||
| Withdrawn |
NCT01707056 -
The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma
|
N/A | |
| Completed |
NCT00094237 -
Subclinical Thyroid Dysfunction and Risk of Myocardial Infarction and Stroke
|
N/A | |
| Recruiting |
NCT06015620 -
Comorbidities Resolution After MGB Surgery and Change in Body Composition
|
||
| Completed |
NCT03612908 -
TSHβX1 and D2 THR92ALA in Pregnancy
|
||
| Completed |
NCT04782856 -
Energy Metabolism in Thyroidectomized Patients
|
Phase 2 | |
| Completed |
NCT01921452 -
Study to Verify Clinical Utility of Point-of-Care (POC) Thyroid Stimulating Hormone (TSH) Test Kits as Compared to Third Generation TSH Test Kit
|
Phase 4 | |
| Completed |
NCT01197183 -
Observational Study With Prospective and/or Retrospective Follow-up, Without Modifying Patient Treatment and Follow-up Practices for the Initial Treatment of Hypothyroidism in France
|
N/A | |
| Recruiting |
NCT05247476 -
Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.
|
Phase 4 | |
| Recruiting |
NCT03754621 -
Upper Limit for TSH of First and Second Trimester Pregnancy in Turkey
|
||
| Completed |
NCT02959827 -
Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States
|
||
| Completed |
NCT04124705 -
A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants
|
Phase 2 | |
| Withdrawn |
NCT02577367 -
Mean Percentage of Levothyroxine Dosage Increase in Patients With Hypothyroidism Started on Enteral Feeding
|
Phase 4 | |
| Completed |
NCT04098991 -
Improving White Matter Integrity With Thyroid Hormone
|
||
| Not yet recruiting |
NCT03257566 -
Hypothyroidism in Patients With Type 1 Diabetes
|
N/A | |
| Terminated |
NCT02567877 -
Is Levothyroxine Alone Adequate Thyroid Hormone Replacement?
|
||
| Completed |
NCT02280330 -
Iodine Status of Preschoolers Given Micronutrient Powder for 6 Months
|
Phase 4 | |
| Completed |
NCT00403390 -
Generic vs. Name-Brand Levothyroxine
|
N/A | |
| Not yet recruiting |
NCT06096454 -
Effect of Life Style Modification and Metformin on Hypothyroidism With Insulin Resistance
|
Phase 4 |